The co-occurrence of substance use disorders (SUDs) and psychiatric conditions, often
referred to as comorbidity or concurrent disorders, presents intricate challenges in both …

La concurrencia de depresión y un trastorno por uso de sustancias (TUS) en pacientes que
presentan patología dual ha sido reconocida desde hace mucho tiempo como una …

Background: Expectancies, motives, and attitudes toward substances are cognitive factors
that partially account for substance use; however, existing measures tend to have …

Objective Substance use disorders (SUD) are frequently comorbid with other psychiatric
conditions, but a comprehensive diagnostic assessment is often not feasible clinically …

Amidst the opioid epidemic, harm reduction-oriented approaches have gained traction,
including interventions that focus on prescribing pharmaceutical-grade psychoactive …

Purpose Few studies and no theory-based scales have addressed specific barriers to
substance use disorder (SUD) treatment retention. The current study, building on the Theory …

The co-occurrence of substance use disorders (SUD) and other mental disorders (OMD) is
assumed to be high, but the details are uncertain in Spain. The objective of the present study …

Substance use and mental ill health constitute a major public health burden, and a key
global policy priority is to reduce illicit and other harmful substance use. Amphetamine-type …

The provision of integrated care (IC) across alcohol and other drug (AOD) and mental health
(MH) services represents the best practice, yet the consistent delivery of IC in routine …

Introduction Antipsychotic polypharmacy is prevalent, however literature on antipsychotic
polypharmacy during treatment among patients with dual diagnosis is largely non-existent …